GlassScriptPhysician profile
Joseph Boucree
NPI 1730110263
$7,144.37
in general payments reported to CMS, 2019-2025
18 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $333 · 2020: $215 · 2021: $568 · 2022: $1,531 · 2023: $3,902 · 2024: $476 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,257 · Food and Beverage: $1,241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,257.39 |
| Food and Beverage | $1,240.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $5,682.45 | 2022-2024 | Other - Miscellaneous, Lif, Battalion Plif - Ps |
| Spineology INC. | $280.73 | 2021 | |
| Si-Bone, INC. | $191.71 | 2021-2023 | |
| Biom'Up France Sas | $171.01 | 2020 | |
| Medtronic, INC. | $159.72 | 2021 | |
| Stryker Corporation | $144.26 | 2019 | |
| Medtronic USA, INC. | $106.01 | 2019-2020 | |
| Radius Health, INC. | $63.28 | 2019-2021 | |
| Cpm Medical Consultants, LLC | $63.09 | 2019 | |
| Arbor Pharmaceuticals, INC. | $58.91 | 2019-2021 | |
| Globus Medical, INC. | $47.07 | 2025 | Senza |
| Vertex Pharmaceuticals Incorporated | $41.25 | 2024-2025 | |
| Augmedics INC. | $38.06 | 2024 | Xvision |
| Atland Pharmaceuticals, LLC | $28.43 | 2025 | Orphenadrine Citrate, Aspirin and Caffeine, Tolmetin Sodium |
| Biocomposites INC | $24.73 | 2025 | Stimulan |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $16.50 | 2020 | |
| Heron Therapeutics, INC. | $15.15 | 2023 | Zynrelef |
| Providence Medical Technology, INC. | $12.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Boucree listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.